Stop using now Drug recall · FDA · Published July 12, 2024

SoloVital Umary Recall: Undeclared Drugs in Hyaluronic Acid Capsules

SoloVital recalls Umary Acido Hialuronico caplets due to undeclared Diclofenac and Omeprazole. Check your bottle lots for this Class I drug recall.

Plain-English summary generated from official FDA data by GovInfoNow · Published by Carlos Caban · How we make summaries

🇺🇸 FDA recall #D-0620-2024Drug SoloVital ›

Stop using this now

Marketed without an Approved NDA/ANDA: FDA analysis found product to be tainted with undeclared Diclofenac and Omeprazole.

Take action

Contact the company

Recalling firmSoloVital2571 Mast Way, #203 · Chula Vista, CA 91914-4539

✎ GovInfoNow plain-language explainer

SoloVital is recalling Umary Acido Hialuronico, a dietary supplement sold in 30-count bottles of 850 mg caplets. The FDA found the product was tainted with undeclared prescription drugs Diclofenac and Omeprazole. This is classified as a Class I recall, indicating a serious health risk. Read more at govinfonow.com/recall/32587-solovital-umary-recall-undeclared-drugs-in-hyaluronic-acid-capsules.

Source Summary by GovInfoNow · govinfonow.com/recall/32587-solovital-umary-recall-undeclared-drugs-in-hyaluronic-acid-capsules · Updated October 9, 2026 · FDA enforcement record: FDA #D-0620-2024

Cite this page

“SoloVital Umary Recall: Undeclared Drugs in Hyaluronic Acid Capsules.” GovInfoNow, updated October 9, 2026. https://govinfonow.com/recall/32587-solovital-umary-recall-undeclared-drugs-in-hyaluronic-acid-capsules. Based on FDA recall #D-0620-2024 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0620-2024%22&limit=1).

The Food and Drug Administration announced on July 12, 2024, that SoloVital is recalling Umary Acido Hialuronico supplements due to undeclared Diclofenac and Omeprazole. The agency classified the Class I recall as voluntary.

How to tell if you have it

Brand: SoloVital
Product: Umary Acido Hialuronico Supplements
Description: Umary Acido Hialuronico, Suplemento Alimenticio, 850 mg caplets, packaged in 30-count bottles
Quantity: 1,331 bottles
Distribution: Nationwide within the United States

The hazard

FDA analysis found the product to be tainted with undeclared Diclofenac and Omeprazole. The supplements were marketed without an Approved NDA/ANDA.

Context

GovInfoNow's records show other recent recalls of similar products include Buy-Herbal Kian Pee Wan Capsules Recall (2026-03-21) and StuffbyNainax MR 7 SUPER 700000 Capsules: FDA Finds Undeclared Sildenafil and Tadalafil (2025-12-15). Taro Recalls Children's Ibuprofen Due to Foreign Substance occurred on 2026-03-02.

How to tell if you have this one

Look for SoloVital brand Umary Acido Hialuronico, Suplemento Alimenticio, 850 mg caplets packaged in 30-count bottles. The recall covers all lots within the specified Expiry date range distributed nationwide.

Brand
SoloVital
Category
Drug

Based on the official FDA remedy

What to do — step by step

Stop Using Immediately
Cease consumption of the recalled Umary Acido Hialuronico caplets right away due to the presence of undeclared prescription drugs.
Check Your Bottle
Verify if you own the product by checking for the SoloVital brand, 850 mg caplets in 30-count bottles, and lot numbers within the Expiry date range.
Contact Manufacturer
Reach out to SoloVital for further instructions on disposal or return, as specific remedy details are not provided in the record.

Where it went and when

Where it was distributed

Distributed nationwide.

FDA distribution: “Nationwide within the United States” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA published this recall 26 days after the firm started it.

Jul 12, 2024Firm started the recall
Jul 29, 2024FDA classified it Class I
Aug 7, 2024Published in FDA’s Enforcement Report

Dates from the agency record only; steps without a date are left out.

✎ GovInfoNow

Questions people ask

From the GovInfoNow team · based on the FDA notice · How we make summaries

How many bottles are affected by this recall?

Approximately 1,331 bottles are included in this recall.

Similar recalls

Latest drug recalls

Keep exploring

Link to this recall

<a href="https://govinfonow.com/recall/32587-solovital-umary-recall-undeclared-drugs-in-hyaluronic-acid-capsules">SoloVital Umary Recall: Undeclared Drugs in Hyaluronic Acid Capsules (GovInfoNow)</a>

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

Official source: FDA Recall #D-0620-2024 (July 12, 2024) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0620-2024 to see it in context.
Plain-language summary written by qwen3.6:35b-a3b on October 9, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.